Successful Outcome of a Patient with Concomitant Pancreatic and Renal Carcinoma Receiving Secoisolariciresinol Diglucoside Therapy Alone: A Case Report

References

• Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029–3030. doi:10.1002/cncr.33587
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca a Cancer J Clinicians. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Zhao P, Li L, Jiang X, Li Q. Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy. J Hematol Oncol. 2019;12(1):54. doi:10.1186/s13045-019-0738-1
   PubMed Web of Science ®Google Scholar
• Thanarajasingam G, Minasian LM, Baron F, et al. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. Lancet Haematol. 2018;5(11):e563–e598. doi:10.1016/S2352-3026(18)30051-6
   PubMed Web of Science ®Google Scholar
• Malyszko J, Tesarova P, Capasso G, Capasso A. The link between kidney disease and cancer: complications and treatment. Lancet. 2020;396(10246):277–287. doi:10.1016/S0140-6736(20)30540-7
   PubMed Web of Science ®Google Scholar
• Barnes H, See K, Barnett S, Manser R. Surgery for limited-stage small-cell lung cancer. Cochrane Database Syst Rev. 2017;4(4):CD011917. doi:10.1002/14651858.CD011917.pub2
   PubMedGoogle Scholar
• Lin S, Hoffmann K, Schemmer P. Treatment of hepatocellular carcinoma: a systematic review. Liver Cancer. 2012;1(3–4):144–158. doi:10.1159/000343828
   PubMed Web of Science ®Google Scholar
• Grossberg AJ, Chu LC, Deig CR, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. Ca a Cancer J Clinicians. 2020;70(5):375–403. doi:10.3322/caac.21626
   PubMed Web of Science ®Google Scholar
• Topalian SL, Taube JM, Pardoll DM. Neoadjuvant checkpoint blockade for cancer immunotherapy. Science. 2020;367:6477. doi:10.1126/science.aax0182
   Web of Science ®Google Scholar
• Ganesh K, Stadler ZK, Cercek A, et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol. 2019;16(6):361–375. doi:10.1038/s41575-019-0126-x
   PubMed Web of Science ®Google Scholar
• Dhar R, Seethy A, Singh S, et al. Cancer immunotherapy: recent advances and challenges. J Cancer Res Ther. 2021;17(4):834–844. doi:10.4103/jcrt.JCRT_1241_20
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. Ca a Cancer J Clinicians. 2022;72(1):7–33. doi:10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• Jiang H, Hegde S, Knolhoff BL, et al. Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy. Nature Med. 2016;22(8):851–860. doi:10.1038/nm.4123
   PubMed Web of Science ®Google Scholar
• Pecoraro C, De Franco M, Carbone D, et al. 1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: synthesis and pharmacological evaluation. Eur J Med Chem. 2023;249(115134):115134. doi:10.1016/j.ejmech.2023.115134
   PubMedGoogle Scholar
• Valles-Marti A, Mantini G, Manoukian P, et al. Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma. Cell Rep. 2023;42(6):112581.
   PubMed Web of Science ®Google Scholar
• Wang Y, Suarez ER, Kastrunes G, et al. Evolution of cell therapy for renal cell carcinoma. Mol Cancer. 2024;23(1):8. doi:10.1186/s12943-023-01911-x
   PubMed Web of Science ®Google Scholar
• Wang Z, An HW, Hou D, et al. Addressable peptide self-assembly on the cancer cell membrane for sensitizing chemotherapy of renal cell carcinoma. Adv Mater. 2019;31(11):e1807175. doi:10.1002/adma.201807175
   PubMed Web of Science ®Google Scholar
• Xu W, Atkins MB, McDermott DF. Checkpoint inhibitor immunotherapy in kidney cancer. Nat Rev Urol. 2020;17(3):137–150. doi:10.1038/s41585-020-0282-3
   PubMed Web of Science ®Google Scholar
• Toure A, Xueming X. Flaxseed lignans: source, biosynthesis, metabolism, antioxidant activity, bio-active components, and health benefits. Compr Rev Food Sci Food Saf. 2010;9(3):261–269. doi:10.1111/j.1541-4337.2009.00105.x
   PubMed Web of Science ®Google Scholar
• Parikh M, Maddaford TG, Austria JA, Aliani M, Netticadan T, Pierce GN. Dietary Flaxseed as a Strategy for Improving Human Health. Nutrients. 2019;11(5):1171. doi:10.3390/nu11051171
   PubMed Web of Science ®Google Scholar
• DeLuca JAA, Garcia-Villatoro EL, Allred CD. Flaxseed bioactive compounds and colorectal cancer prevention. Curr Oncol Rep. 2018;20(8):59. doi:10.1007/s11912-018-0704-z
   PubMed Web of Science ®Google Scholar
• Calado A, Neves PM, Santos T, Ravasco P. The effect of flaxseed in breast cancer: a literature review. Frontiers in Nutrition. 2018;5:4. doi:10.3389/fnut.2018.00004
   PubMed Web of Science ®Google Scholar
• Lampe JW, Kim E, Levy L, et al. Colonic mucosal and exfoliome transcriptomic profiling and fecal microbiome response to a flaxseed lignan extract intervention in humans. Am J Clin Nutrit. 2019;110(2):377–390. doi:10.1093/ajcn/nqy325
   PubMed Web of Science ®Google Scholar
• Lagkouvardos I, Klaring K, Heinzmann SS, et al. Gut metabolites and bacterial community networks during a pilot intervention study with flaxseeds in healthy adult men. Mol Nutr Food Res. 2015;59(8):1614–1628. doi:10.1002/mnfr.201500125
   PubMed Web of Science ®Google Scholar
• Miyaguni T, Muto Y, Kusano T, Yamada M, Matsumoto M, Shiraishi M. Synchronous double cancers of the remnant stomach and pancreas: report of a case. Surgery Today. 1995;25(12):1038–1042. doi:10.1007/BF00311689
   PubMed Web of Science ®Google Scholar
• Eriguchi N, Aoyagi S, Hara M, et al. Synchronous or metachronous double cancers of the pancreas and other organs: report on 12 cases. Surgery Today. 2000;30(8):718–721. doi:10.1007/s005950070083
   PubMed Web of Science ®Google Scholar
• Gerdes B, Ziegler A, Ramaswamy A, Wild A, Langer P, Bartsch DK. Multiple primaries in pancreatic cancer patients: indicator of a genetic predisposition? Int J Epidemiol. 2000;29(6):999–1003. doi:10.1093/ije/29.6.999
   PubMed Web of Science ®Google Scholar
• Mahfoud T, Tanz R, Khmamouche MR, et al. Synchronous primary renal cell carcinoma and pancreatic ductal adenocarcinoma: case report and literature review. Case Rep Oncol. 2017;10(3):1050–1056. doi:10.1159/000484552
   PubMedGoogle Scholar
• De Silva SF, Alcorn J. Flaxseed lignans as important dietary polyphenols for cancer prevention and treatment: chemistry, pharmacokinetics, and molecular targets. Pharmaceuticals. 2019;12(2). doi:10.3390/ph12020068
   Web of Science ®Google Scholar
• Hao Wu YW, Chen J, Wang L, Liu G, Shulin L, Liu S-L. Anticancer effects of dietary administration of secoisolariciresinol diglucoside in a patient of gastrointestinal stromal tumor: a case report. Internat J Surg Oncol. 2021;5:e103. doi:10.1097/IJ9.0000000000000103
   Google Scholar
• de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020–1032. doi:10.1136/gutjnl-2021-326789
   PubMed Web of Science ®Google Scholar
• Hou K, Wu ZX, Chen XY, et al. Microbiota in health and diseases. Signal Transd Target Ther. 2022;7(1):135. doi:10.1038/s41392-022-00974-4
   PubMed Web of Science ®Google Scholar
• Park EM, Chelvanambi M, Bhutiani N, Kroemer G, Zitvogel L, Wargo JA. Targeting the gut and tumor microbiota in cancer. Nature Med. 2022;28(4):690–703. doi:10.1038/s41591-022-01779-2
   PubMed Web of Science ®Google Scholar
• Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science. 2021;371:6536. doi:10.1126/science.abc4552
   Web of Science ®Google Scholar
• Wang CZ, Ma XQ, Yang DH, et al. Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria. BMC Microbiol. 2010;10(115). doi:10.1186/1471-2180-10-115
   Google Scholar
• Possemiers S, Bolca S, Eeckhaut E, Depypere H, Verstraete W. Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community. FEMS Microbiol Ecol. 2007;61(2):372–383. doi:10.1111/j.1574-6941.2007.00330.x
   PubMed Web of Science ®Google Scholar
• Zhuang H, Cheng L, Wang Y, et al. Dysbiosis of the gut microbiome in lung cancer. Front Cell Infect Microbiol. 2019;9:112. doi:10.3389/fcimb.2019.00112
   PubMed Web of Science ®Google Scholar
• Liu H, Liu J, Wang S, et al. Enterolactone has stronger effects than enterodiol on ovarian cancer. Jovarian Res. 2017;10(1):49. doi:10.1186/s13048-017-0346-z
   PubMedGoogle Scholar
• Tao YL, Yang DH, Zhang YT, et al. Cloning, expression, and characterization of the beta-glucosidase hydrolyzing secoisolariciresinol diglucoside to secoisolariciresinol from Bacteroides uniformis ZL1. Appl Microbiol Biotechnol. 2014;98(6):2519–2531. doi:10.1007/s00253-013-5111-7
   PubMed Web of Science ®Google Scholar
• Wang YF, Xu ZK, Yang DH, et al. The antidepressant effect of secoisolariciresinol, a lignan-type phytoestrogen constituent of flaxseed, on ovariectomized mice. J Nat Med. 2013;67(1):222–227. doi:10.1007/s11418-012-0655-x
   PubMed Web of Science ®Google Scholar
• Li MX, Zhu HY, Yang DH, et al. Production of secoisolariciresinol from defatted flaxseed by bacterial biotransformation. J Appl Microbiol. 2012;113(6):1352–1361. doi:10.1111/j.1365-2672.2012.05436.x
   PubMed Web of Science ®Google Scholar
• Zhu Hongyun LM, Donghui Y, Yilun T, Ying Z, Shulin L. Biotransformation of the SDG in defatted flaxseed into END co-cultured by three single bacterial colonies. Process Biochem. 2013;49(2014):19–24.
   Google Scholar